Singular Genomics Systems Inc. (OMIC) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Singular Genomics Systems... (OMIC)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

19.78

0.07 (0.36%)

At close: Jan 14, 2025, 3:58 PM

19.80

0.10%

After-hours Jan 14, 2025, 03:59 PM EST

undefined% (undefined)

Bid	19.15
Market Cap	50.12M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-34.68
PE Ratio (ttm)	-0.57
Forward PE	n/a
Analyst	Hold

Ask	19.83
Volume	8,748
Avg. Volume (20D)	23,522
Open	19.87
Previous Close	19.71
Day's Range	19.64 - 19.90
52-Week Range	5.34 - 23.41
Beta	undefined

About OMIC

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, s...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date May 27, 2021

Employees 255

Stock Exchange NASDAQ

Ticker Symbol OMIC

Website https://singulargenomics.com

Analyst Forecast

According to 2 analyst ratings, the average rating for OMIC stock is "Hold." The 12-month stock price forecast is $10.75, which is a decrease of -45.65% from the latest price.

Buy 0.00%

Hold 100.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Singular Genomics Systems Inc. is scheduled to release its earnings on Mar 17, 2025, during market hours.
Analysts project revenue of $1.77M, reflecting a 63.74% YoY growth and earnings per share of -7.85, making a -18.23% decrease YoY.

Why Price Moved

4 months ago · Source

+119.12%

Singular Genomics shares are trading higher after ... Unlock content with Pro Subscription

4 months ago · Source

-0.35%

Singular Genomics shares are trading higher after the company announced it received a non-binding acquisition proposal from Deerfield

News

1 week ago · businesswire.com

SINGULAR GENOMICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Singular Genomics Systems, Inc. - OMIC

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Singular Genomic...

3 weeks ago · businesswire.com

OMIC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Singular Genomics Systems, Inc. Is Fair to Shareholders

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Singular Genomics Systems, Inc. (NASDAQ: OMIC) to an affiliate of Deerfield Management Co...

3 weeks ago · businesswire.com

Shareholder Alert: Ademi LLP Investigates Whether Singular Genomics Systems, Inc. is Obtaining a Fair Price for Its Public Shareholders

MILWAUKEE--(BUSINESS WIRE)--Ademi LLP is investigating Singular Genomics (Nasdaq: OMIC) for possible breaches of fiduciary duty and other violations of law in its transaction with the Deerfield. Click...